We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OGEN market cap is 4.26M. The company's latest EPS is USD -0.4921 and P/E is -0.39.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.8M | -2.46M | -2.31M | -2.44M | -3.36M |
| Net Income | -12.75M | -2.45M | -2.31M | -2.46M | -3.35M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 87k | 132k | 38k | 0 |
| Operating Income | -26.64M | -15.77M | -14.42M | -20.91M | -10.56M |
| Net Income | -26.43M | -15.71M | -14.29M | -20.66M | -10.57M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.97M | 3.53M | 2.71M | 5.2M | 1.47M |
| Total Liabilities | 1.8M | 909k | 1.38M | 2.13M | 1.69M |
| Total Equity | 3.17M | 2.63M | 1.33M | 3.08M | -212k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.68M | 28.23M | 14.76M | 4.97M | 1.47M |
| Total Liabilities | 1.84M | 1.75M | 1.75M | 1.8M | 1.69M |
| Total Equity | 16.85M | 26.49M | 13.01M | 3.17M | -212k |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.29M | -3.06M | -4.61M | -6.58M | -8.6M |
| Investing | -936k | N/A | N/A | N/A | N/A |
| Financing | 284k | 1.65M | 2.47M | 6.24M | 5.98M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.95M | -13.47M | -15.23M | -7.29M | -8.6M |
| Investing | N/A | -44k | -116k | -936k | N/A |
| Financing | 16.33M | 23.14M | -495k | 284k | 5.98M |
| Market Cap | 4.26M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.71 |
| Price to Book Ratio | -19.25 |
| Dividend Yield | - |
| Shares Outstanding | 21.48M |
| Average Volume (1 week) | 233.89k |
| Average Volume (1 Month) | 381.34k |
| 52 Week Change | -81.95% |
| 52 Week High | 3.43 |
| 52 Week Low | 0.1617 |
| Spread (Intraday) | 0.01 (6.7%) |
| Company Name | Oragenics Inc |
| Address |
101 east kennedy boulevard tampa, florida 33602 |
| Website | https://www.oragenics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
